Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.

Saved in:
Bibliographic Details
Title: Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.
Authors: Petrova MP; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Donev IS; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Radanova MA; Department of Biochemistry and Molecular Medicine, Medical University of Varna, Varna, Bulgaria., Eneva MI; Hospital Pharmacy 'Nadezhda', Sofia, Bulgaria., Dimitrova EG; Clinic of Medical Oncology, UMHAT 'St Marina', Varna, Bulgaria., Valchev GN; Radiology Department, UMHAT 'St Marina', Varna, Bulgaria., Minchev VT; Department of Medical Oncology, University Hospital Sofiamed, Sofia, Bulgaria., Taushanova MS; Department of Medical Oncology, University Hospital Sofiamed, Sofia, Bulgaria., Boneva MV; Radiology Department, University Hospital Sofiamed, Sofia, Bulgaria., Karanikolova TS; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Gencheva RB; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Zhbantov GA; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Ivanova AI; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Timcheva CV; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., P Pavlov B; Radiology Department, MHAT 'Nadezhda', Sofia, Bulgaria., Megdanova VG; Deparment of Medical Oncology, UMHAT 'St Giovanna', Sofia, Bulgaria., Robev BS; Oncology Unit, University Hospital 'St Ivan Rilski', Sofia, Bulgaria., Conev NV; Clinic of Medical Oncology, UMHAT 'St Marina', Varna, Bulgaria.
Source: Clinical and experimental immunology [Clin Exp Immunol] 2020 Dec; Vol. 202 (3), pp. 353-362. Date of Electronic Publication: 2020 Aug 26.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2249
DOI:10.1111/cei.13505